Risk of Diagnosis of Ovarian Cancer After Raised Serum CA 125 Concentration: A Prospective Cohort Study

BMJ
doi 10.1136/bmj.313.7069.1355
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Diagnostic Performance of CA 125, HE4, and Risk of Ovarian Malignancy Algorithm for Ovarian Cancer

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

The Role of CA‐125 in the Management of Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
1997English

Serum McA, CA 125 and CA 19.9 Determination in Primary Breast Cancer

Biochemical Society Transactions
Biochemistry
1996English

A Prospective Cohort Study of Dietary Indices and Incidence of Epithelial Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2014English

Serum Pepsinogen Level, Atrophic Gastritis and the Risk of Incident Pancreatic Cancer—A Prospective Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2009English

Nadir CA-125 Level as Prognosis Indicator of High-Grade Serous Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Risk of a Second Primary Cancer After Non-Melanoma Skin Cancer in White Men and Women: A Prospective Cohort Study

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2013English

Monitoring Ovarian Carcinoma With CA 125, CA 19–9, CA 15–3 and CEA in Serum, Ascites and Tumor Tissue

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Serum 25-Hydroxyvitamin D and Cancer Risk in Older Adults: Results From a Large German Prospective Cohort Study

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy